Hypogonadism, Male

Hypogonadism, Male

 

Hypogonadism is one of the most common endocrine disorders in men, and is characterized by low serum testosterone levels with clinical signs and symptoms of the disease.

Epidemiology

  • Prevalence
    • Estimated 4-5 million men in U.S. have hypogonadism
    • 20% of men 60 or older have hypogonadism
    • Frequency increases with obesity, type II diabetes mellitus, aging

Etiologies

  • Primary (pathology in testes)
    • Autoimmune orchitis
    • Chemotherapy
    • Cryptorchidism
    • Dysgenetic testes
    • Klinefelter syndrome
    • Mumps orchitis
    • Myotonic dystrophy
    • Orchiectomy
    • Radiation
  • Secondary (pathology in pituitary)
    • Alcohol abuse
    • Cushing syndrome
    • Drugs (corticosteroids, opiates)
    • Hyperprolactinemia
    • Iron overload
    • Pituitary lesions
    • Severe chronic illness (cancer, chronic liver disease, chronic renal disease, rheumatoid arthritis, diabetes melitis, obesity)
    • Other genetic mutations
  • Tertiary (pathology in hypothalamus)
    • Kallman syndrome
    • Prader-Willi syndrome
  • Age-related hypogonadism (pathology in testes and hypothalamus)

Pathophysiology

  • Gonadotropin-releasing hormone (GnRH) is secreted from the hypothalamus
  • GnRH stimulates the release of leuteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary
  • LH promotes secretion of testosterone from Leydig cells
  • FSH stimulates spermatogenesis and inhibin B production from Sertoli cells inhibits FSH
  • 2% of circulating testosterone is free; 98% is bound 
    • 60% bound to albumin   
    • 40% bound to sex hormone binding globulin
  • Bioavailable testosterone = free testosterone plus albumin bound testosterone
  • Substantial alterations in sex hormone binding globulin affect total testosterone level
    • Free testosterone and bioavailable testosterone levels more accurately reflect bioactive testosterone under these circumstances

Clinical Presentation

  • Manifestations depend on the age of onset of hypogonadism
  • Pubertal hypogonadism
    • Eunuchoidal body habitus
    • Gynecomastia
    • Small testes
    • Lack of secondary sexual characteristics
  • Postpubertal hypogonadism
  • Weakness
    • Decreased libido
    • Depressed mood
    • Impotence
    • Normal penile size
    • Low bone mineral density
    • Gynecomastia
    • Muscle loss
    • Abdominal adiposity

Diagnosis

  • Indications for testing – signs and symptoms of hypogonadism
  • Laboratory testing
    • Screen with serum testosterone concentration (preferably between 8-10 am)
      • For children, use mass spectrometry assay
      • For adult males, use radioimmunoassay (mass spectrometry not necessary) – <300 ng/dL suggests hypogonadism
    • If total testosterone is abnormal, may consider testing for free testosterone concentrations – helpful in determining bioavailable testosterone
    • FSH/LH to differentiate between primary and secondary etiologies
      • Primary – FSH and LH are elevated
  • Imaging
    • If testosterone <150 ng/dL – consider MRI for pituitary imaging and if  LH is normal to low prolactin may be increased

Differential Diagnosis

  • Pituitary lesions
  • Dementia
  • Hypothyroidism adrenal tumor
  • Depression
  • Diabetes mellitis
  • Hemochromatosis
  • Cystic fibrosis

Treatment

  • Androgen replacement

See Also